Voyager Therapeutics, Inc. (VYGR) › Net IncomeVoyager Therapeutics, Inc. (VYGR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$16.32M2015: -$29.67M2016: -$40.19M2017: -$70.70M2018: -$88.29M2019: -$43.60M2020: $36.74M2021: -$71.20M2022: -$46.41M2023: $132.33M2024: -$65.00M2025: -$119.72M-$119.72M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$119.72M-84.2%2024-$65.00M-149.1%2023$132.33M+385.1%2022-$46.41M+34.8%2021-$71.20M-293.8%2020$36.74M+184.3%2019-$43.60M+50.6%2018-$88.29M-24.9%2017-$70.70M-75.9%2016-$40.19M-35.5%2015-$29.67M-81.8%2014-$16.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share